$19.450
-0.325 (-1.67%)Al cierre
Rentabilidad y márgenes de SBRA
Evaluating the bottom line, Sabra Health Care REIT, Inc. maintains a gross margin of 62.43%. This metric reflects the company's pricing power and manufacturing efficiency. Further down the income statement, the operating margin stands at -13.59%, while the net margin is -10.70%. These profitability ratios, combined with a Return on Equity (ROE) of 2.40%, provide a clear picture of how effectively SBRA converts its operational activities into shareholder value.
Comparativa sectorial de SBRA
In the context of the broader market, SBRA competes directly with industry leaders such as OGCP and CUZ. With a market capitalization of $5.00B, it holds a leading position in the sector. When comparing efficiency, SBRA's gross margin of 62.43% stands against OGCP's N/A and CUZ's 29.28%. Such benchmarking helps identify whether Sabra Health Care REIT, Inc. is trading at a premium or discount relative to its financial performance.
Desempeño financiero de Sabra Health Care REIT Inc
The company has shown strong revenue growth, with Q2 2026 revenue reaching $235.87 million, up from $221.75 million in Q1 2026. However, it reported a net loss in Q2 2026, which raises concerns about short-term profitability.
Financials
Esta página es solo para investigación y no constituye asesoramiento de inversión. Los modelos pueden equivocarse. El rendimiento pasado no garantiza resultados futuros.